Thursday, March 14, 2013
Image source: insidethegames.biz
Every day, Lance Armstrong loses one medal from all the accolades and praises he has received during his heydays. And each day, the world seems to become more and more unstoppable from belittling the once-extoled cycling superstar by making him a regular in evening news headlines.
But everyone understands the public rage. Armstrong has had to lie a hundred times in front of the camera before he came to a conclusion that saying the truth is the best thing to do.
Image source: media.tumblr.com
In sports, doping related-cases aren’t really that big in number since a case has to undergo a series of investigations before it can be considered as such—otherwise, it remains a sheer accusation, like those of Floyd Mayweather Jr. and of Manny Pacquiao. What is growing is the number of pharmaceutical companies and athletic organizations that are partnering with each other to eradicate the numbers of legal drugs that seem to become illegal due to some athletes’ misusage, like in Armstrong’s and other cyclists’ case. GlaxoSmithKline and Roche have already volunteered to share their products’ information to World Anti-Doping Agency (WADA) for its potential to be used by athletes, which, according to many sports analysts, is a great start that would coax many drug companies to do the same thing.
In that regard, the Armstrong case has given the sporting world a piece of good news.
Image source: portuguese-american-journal.com
For a glimpse into sports and athleticism, log on to Brad Pyatt’s company website.